http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004053146-A2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_18fb68f06971993266586587ae83a5d4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_58c2183c4598b8e1ae095bb288001f9e |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-00 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-18 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-18 |
filingDate | 2003-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b52e8cf340975e38dee9168ea79c6778 |
publicationDate | 2004-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | WO-2004053146-A2 |
titleOfInvention | Sec14 as an antifungal target |
abstract | The invention provides SEC14 cytosolic factor (SEC14) as a novel antifungal target, screening methods for SEC14 inhibitors and their use as antifungal compounds, pharmaceutical compositions containing them and their use in medicine, specifically in the treatment of an individual susceptible to or suffering from an anti-fungal infection. In particular the compounds find use in the treatment of topical or mucosal (e.g. thrush and vaginal candidiasis) fungal infections, e.g. caused by fungus of the Candida species, and systemic infections, e.g. caused by fungi of Candida and Aspergillus species, such as but not limited to C. albicans, Aspergillus flavus or Aspergillus fumigatus. |
priorityDate | 2002-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 953.